The genotoxicity laboratory can provide reliable preliminary screening tests for mutagenicity and potential carcinogenesis of new drugs based on the guiding principles of ICH, NMPA and FDA so as to meet the application demands of customers.

●Service type:

1. Ames test;

2. Cell chromosome aberration test;

3. Mouse bone marrow micronucleus test.